1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow CastleVax Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults NDV-HXP-S-KP.2, COVID-19 mRNA Vaccine - COVID-19 | Phase 2 | Active not recruiting | CastleVax Inc. | 200 | 2025-11-03 | 2026-07-22 |
COVID-19 (1)
United States (1)